News Room

All Press Releases In The News Blogs
17 Dec 2015
Press Release
Egalet Added to NASDAQ Biotechnology Index 
Egalet (NASDAQ:EGLT)
16 Dec 2015
Press Release
Versartis' VRS-317 6-Month Data Published in The Journal of Clinical Endocrinology & Metabolism 
Versartis (NASDAQ: VSAR)
15 Dec 2015
Press Release
Journal of the American Medical Association (JAMA) Publishes Pivotal Phase 3 Data for Optune Plus Temozolomide to Treat Newly Diagnosed Glioblastoma 
Novocure (NASDAQ: NVCR)
07 Dec 2015
Press Release
ARIAD Announces Initiation of OPTIC-2L Randomized Phase 3 Trial of ponatinib vs. nilotinib in Second-Line Patients with Chronic-Phase Chronic Myeloid Leukemia 
Ariad - Acquired by Takeda (NASDAQ: ARIA)
09 Nov 2015
Press Release
Acutus Medical Announces Presentation of AcQMap High Resolution Imaging and Mapping System Data at the 2015 American Heart Association Scientific Sessions 
Acutus Medical
19 Mar 2015
Press Release
Janssen Acquires XO1 Limited 
Xo1 - Acquired by Janssen Pharmaceuticals (NASDAQ: JNJ)
19 Mar 2015
Blog
Janssen Pharmaceuticals acquires 100% of XO1
by Francesco De Rubertis
11 Feb 2015
Press Release
GlycoVaxyn AG sells its shares to GSK 
GlycoVaxyn - Acquired by GSK (London: GSK.L)
11 Feb 2015
Blog
Glycovaxyn: the vision of a brilliant ETHZ biochemist turns into reality
by Francesco De Rubertis
09 Jan 2015
Press Release
CoMentis and Anvyl Announce the Initiation of Clinical Trials for APN1125 for the Treatment of Schizophrenia 
CoMentis
18 Dec 2014
Press Release
Merck Acquires OncoEthix, a Privately Held Oncology Company Developing Novel BET Inhibitors for Hematological and Solid Cancers 
Oncoethix - Acquired by Merck (NYSE.MRK)
17 Oct 2013
Blog
Clinical Trial Transparency
by David Grainger
04 Sep 2013
Blog
Platform Technologies
by David Grainger
14 Aug 2013
Blog
The Man Who Cured Ageing?
by David Grainger
06 Aug 2013
Blog
ProFibrix, a rising star of pharma companies
by Francesco De Rubertis
31 Jul 2013
Blog
The zero person biotech company
by David Grainger
16 Jul 2013
Blog
Incremental innovation lives on
by David Grainger
17 Jun 2013
Blog
Ichorcumab: the blood of the gods?
by David Grainger
20 May 2013
Blog
Where to start an ‘Asset-Centric’ Biotech Firm?
by Kevin Johnson
25 Oct 2012
Blog
Gianni Garotta: on to the next thing
by Francesco De Rubertis
19 Oct 2012
Blog
Playground 1.0
by Kevin Johnson
17 Oct 2012
Blog
The Lionel Messi of Biology?
by Francesco De Rubertis
16 Apr 2012
Blog
There’s something about entrepreneurs
by Kevin Johnson
21 Mar 2012
Blog
The Index Asset-Centric Platform
by Kevin Johnson
21 Mar 2012
Blog
The “Asset Centric” investing model
by Michèle Ollier
16 Mar 2012
Blog
Micromet: a BiTE at cancer?
by Francesco De Rubertis
07 Feb 2012
Blog
Is "more" always "better" for biotech start ups?
by Francesco De Rubertis